Cargando…

Disseminated non-tuberculous mycobacterial infection caused by Mycobacterium obuense in an immunocompromised patient: a case report

BACKGROUND: Mycobacterium obuense (M. obuense) is a rapidly growing mycobacterium (RGM) which has been considered nonpathogenic. Here, we report a case of disseminated non-tuberculous mycobacterial (NTM) infection caused by M. obuense in an immunocompromised patient. CASE PRESENTATION: A 16-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naito, Maiko, Fukushima, Kentaro, Kusakabe, Shinsuke, Endo, Takaya, Shiroyama, Takayuki, Ohira, Kika, Azuma, Koji, Tanizaki, Satoshi, Yamamoto, Yumiko, Hosono, Yuki, Naito, Yujiro, Futami, Shinji, Miyake, Kotaro, Hirata, Haruhiko, Takeda, Yoshito, Kumanogoh, Atsushi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408174/ https://www.ncbi.nlm.nih.gov/pubmed/37550642 http://dx.doi.org/10.1186/s12879-023-08510-7

Ejemplares similares

Leucine-rich a-2 glycoprotein as a potential biomarker of idiopathic multicentric Castleman disease with pulmonary involvement: a single-center case-control study from Japan
por: Takata, So, et al.
Publicado: (2022)

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
por: Tone, Mari, et al.
Publicado: (2023)

Mycobacterium obuense Bacteremia in a Patient with Pneumonia
por: Luis, Bruno Ali López, et al.
Publicado: (2019)

Monitoring antibody binding to T cells in a pembrolizumab‐treated patient with lung adenocarcinoma on hemodialysis
por: Osa, Akio, et al.
Publicado: (2019)

Lateral Decubitus Position Enables Further Advancement of the Bronchoscope into the Lung Periphery
por: Miyake, Kotaro, et al.
Publicado: (2022)

Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer
por: Noda, Yoshimi, et al.
Publicado: (2022)

Clinical Characteristics and Mortality of Non-tuberculous Mycobacterial Infection in Immunocompromised vs. Immunocompetent Hosts
por: Chai, Jingjing, et al.
Publicado: (2022)

Management of severe hypertension due to lenvatinib in patients with advanced thymic carcinoma: A case report
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Impact of treatment line on risks and benefits of immune checkpoint inhibitor in patients with advanced non-small cell lung cancer and interstitial lung disease: a systematic review and meta-analysis of cohort studies
por: Matsumoto, Kinnosuke, et al.
Publicado: (2022)

Respiratory Impedance is Associated with Ventilation and Diffusing Capacity in Patients with Idiopathic Pulmonary Fibrosis Combined with Emphysema
por: Yamamoto, Yuji, et al.
Publicado: (2022)

A case of synchronous triple autoimmune disorders secondary to thymoma: Pure red cell aplasia, Good's syndrome, and thymoma-associated multi-organ autoimmunity
por: Nakagawa, Yuta, et al.
Publicado: (2022)

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients
por: Iwahori, Kota, et al.
Publicado: (2022)

Pulmonary metastases of lung adenocarcinoma mimicking COVID-19 pneumonia
por: Shiroyama, Takayuki, et al.
Publicado: (2020)

Suppression of the malignancy of mammary tumor in mice model by inactivated preparation of Mycobacterium obuense
por: Nofouzi, Katayoon, et al.
Publicado: (2022)

Group 2 innate lymphoid cells and their surrounding environment
por: Naito, Maiko, et al.
Publicado: (2023)

A heat-killed preparation of mycobacterium obuense can reduce metastatic burden in vivo
por: Fowler, Daniel, et al.
Publicado: (2014)

Semaphorin 6D–expressing mesenchymal cells regulate IL-10 production by ILC2s in the lung
por: Naito, Maiko, et al.
Publicado: (2022)

Identification of CD14 and lipopolysaccharide-binding protein as novel biomarkers for sarcoidosis using proteomics of serum extracellular vesicles
por: Futami, Yu, et al.
Publicado: (2022)

Non-Tuberculous Mycobacterial Diseases in Children
por: Meoli, Aniello, et al.
Publicado: (2020)

Draft Genome Sequence of Mycobacterium obuense Strain UC1, Isolated from Patient Sputum
por: Greninger, Alexander L., et al.
Publicado: (2015)

Nontuberculous Mycobacterial Pulmonary Disease in an Immunocompromised Patient
por: Singh, Ranjan K, et al.
Publicado: (2019)

1399. Clarithromycin–Rifampin-based Treatment for Non-tuberculous Mycobacterial Infections in Immunocompromised Patients Who Require Concomitant CYP-Metabolized Medications
por: Gonzalez-Bocco, Isabel H, et al.
Publicado: (2021)

Rapid intracranial response to osimertinib, without radiotherapy, in nonsmall cell lung cancer patients harboring the EGFR T790M mutation: Two Case Reports
por: Koba, Taro, et al.
Publicado: (2017)

Textbook of tuberculosis & non-tuberculous mycobacterial diseases
por: Kant, Surya
Publicado: (2021)

COVID-19 in a patient with sporadic lymphangioleiomyomatosis awaiting lung transplantation
por: Noda, Yoshimi, et al.
Publicado: (2021)

Case report: Acute exacerbation of interstitial pneumonia related to messenger RNA COVID-19 vaccination
por: Amiya, Saori, et al.
Publicado: (2022)

Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases
por: Sharma, Surendra K., et al.
Publicado: (2020)

Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease
por: Pennington, Kelly M., et al.
Publicado: (2021)

The roles of neutrophils in non-tuberculous mycobacterial pulmonary disease
por: Alkarni, Meyad, et al.
Publicado: (2023)

L-Tyrosine Limits Mycobacterial Survival in Tuberculous Granuloma
por: Gao, Yaxian, et al.
Publicado: (2023)

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease
por: Niitsu, Takayuki, et al.
Publicado: (2023)

Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
por: Ruth, Mike Marvin, et al.
Publicado: (2020)

Prolonged tedizolid use in cutaneous non-tuberculous mycobacterial infection
por: Shaw, Timothy David, et al.
Publicado: (2021)

Whole Genome Sequencing in the Management of Non-Tuberculous Mycobacterial Infections
por: Dohál, Matúš, et al.
Publicado: (2021)

Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease
por: Kumar, Kartik, et al.
Publicado: (2021)

Characterizing and correcting immune dysfunction in non-tuberculous mycobacterial disease
por: Ratnatunga, Champa N., et al.
Publicado: (2022)

Non-tuberculous mycobacterial disease associated with Mycobacterium montefiorense in salamanders
por: Komine, Takeshi, et al.
Publicado: (2023)

Application of diagnostic criteria for non-tuberculous mycobacterial disease to a case series of mycobacterial-positive isolates
por: Ghio, Andrew J., et al.
Publicado: (2019)

Mycobacterial Tenosynovitis After Sea Urchin Spine Injury in an Immunocompromised Patient
por: Vargas, Christina R, et al.
Publicado: (2018)

CpG ODN (K3)—toll-like receptor 9 agonist—induces Th1-type immune response and enhances cytotoxic activity in advanced lung cancer patients: a phase I study
por: Otsuka, Tomoyuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_57jg0kk9374675smp23etufjd3